TrialThe oncologist2019

Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02).

Xabier García-Albéniz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.